vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 13.91 USD 7.58% Market Closed
Market Cap: 41.9m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one VTVT stock under the Base Case scenario is 8.19 USD. Compared to the current market price of 13.91 USD, vTv Therapeutics Inc is Overvalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VTVT Intrinsic Value
8.19 USD
Overvaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
vTv Therapeutics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for VTVT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about VTVT?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about vTv Therapeutics Inc

Provide an overview of the primary business activities
of vTv Therapeutics Inc.

What unique competitive advantages
does vTv Therapeutics Inc hold over its rivals?

What risks and challenges
does vTv Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in vTv Therapeutics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for vTv Therapeutics Inc.

Provide P/S
for vTv Therapeutics Inc.

Provide P/E
for vTv Therapeutics Inc.

Provide P/OCF
for vTv Therapeutics Inc.

Provide P/FCFE
for vTv Therapeutics Inc.

Provide P/B
for vTv Therapeutics Inc.

Provide EV/S
for vTv Therapeutics Inc.

Provide EV/GP
for vTv Therapeutics Inc.

Provide EV/EBITDA
for vTv Therapeutics Inc.

Provide EV/EBIT
for vTv Therapeutics Inc.

Provide EV/OCF
for vTv Therapeutics Inc.

Provide EV/FCFF
for vTv Therapeutics Inc.

Provide EV/IC
for vTv Therapeutics Inc.

Show me price targets
for vTv Therapeutics Inc made by professional analysts.

What are the Revenue projections
for vTv Therapeutics Inc?

How accurate were the past Revenue estimates
for vTv Therapeutics Inc?

What are the Net Income projections
for vTv Therapeutics Inc?

How accurate were the past Net Income estimates
for vTv Therapeutics Inc?

What are the EPS projections
for vTv Therapeutics Inc?

How accurate were the past EPS estimates
for vTv Therapeutics Inc?

What are the EBIT projections
for vTv Therapeutics Inc?

How accurate were the past EBIT estimates
for vTv Therapeutics Inc?

Compare the revenue forecasts
for vTv Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of vTv Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of vTv Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of vTv Therapeutics Inc compared to its peers.

Compare the P/E ratios
of vTv Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing vTv Therapeutics Inc with its peers.

Analyze the financial leverage
of vTv Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for vTv Therapeutics Inc.

Provide ROE
for vTv Therapeutics Inc.

Provide ROA
for vTv Therapeutics Inc.

Provide ROIC
for vTv Therapeutics Inc.

Provide ROCE
for vTv Therapeutics Inc.

Provide Gross Margin
for vTv Therapeutics Inc.

Provide Operating Margin
for vTv Therapeutics Inc.

Provide Net Margin
for vTv Therapeutics Inc.

Provide FCF Margin
for vTv Therapeutics Inc.

Show all solvency ratios
for vTv Therapeutics Inc.

Provide D/E Ratio
for vTv Therapeutics Inc.

Provide D/A Ratio
for vTv Therapeutics Inc.

Provide Interest Coverage Ratio
for vTv Therapeutics Inc.

Provide Altman Z-Score Ratio
for vTv Therapeutics Inc.

Provide Quick Ratio
for vTv Therapeutics Inc.

Provide Current Ratio
for vTv Therapeutics Inc.

Provide Cash Ratio
for vTv Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for vTv Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for vTv Therapeutics Inc?

What is the current Free Cash Flow
of vTv Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for vTv Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
vTv Therapeutics Inc

Current Assets 46.2m
Cash & Short-Term Investments 45.5m
Receivables 306k
Other Current Assets 368k
Non-Current Assets 258k
PP&E 258k
Current Liabilities 7m
Accounts Payable 6.8m
Accrued Liabilities 177k
Other Current Liabilities 17k
Non-Current Liabilities 23m
Other Non-Current Liabilities 23m
Efficiency

Earnings Waterfall
vTv Therapeutics Inc

Revenue
1m USD
Operating Expenses
-28.1m USD
Operating Income
-27.1m USD
Other Expenses
6.9m USD
Net Income
-20.2m USD

Free Cash Flow Analysis
vTv Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

VTVT Profitability Score
Profitability Due Diligence

vTv Therapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROE
Exceptional ROIC
Exceptional 1-Year Revenue Growth
45/100
Profitability
Score

vTv Therapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

VTVT Solvency Score
Solvency Due Diligence

vTv Therapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

vTv Therapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VTVT Price Targets Summary
vTv Therapeutics Inc

There are no price targets for VTVT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for VTVT?

Click here to dive deeper.

Dividends

vTv Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VTVT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VTVT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

vTv Therapeutics Inc Logo
vTv Therapeutics Inc

Country

United States of America

Industry

Biotechnology

Market Cap

41.9m USD

Dividend Yield

0%

Description

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. The company is headquartered in High Point, North Carolina and currently employs 9 full-time employees. The company went IPO on 2015-07-30. Its products pipeline includes TTP399, TTP273, HPP737 and HPP593. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. Its HPP737 is an orally administered, non- central nervous system (CNS) penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases. TTP273 is an orally available, small molecule glucagon-like peptide 1 (GLP-1) receptor agonist, which is focused on treating postprandial hyperglycemia in cystic fibrosis related diabetes (CFRD) patients and cystic fibrosis patients. Its products pipeline also includes Nrf2/Bach1 Modulator Program.

Contact

NORTH CAROLINA
High Point
3980 Premier Dr, Suite 310
+13368410300.0
vtvtherapeutics.com

IPO

2015-07-30

Employees

9

Officers

CEO, President & Chairman of the Board
Mr. Paul J. Sekhri M.Sc.
Executive VP & CFO
Mr. Steven Tuch M.B.A.
Chief Scientific Officer & Executive VP
Dr. Carmen Valcarce Ph.D.
Executive VP & General Counsel
Ms. Elizabeth M. Keiley
Executive VP of Corporate Development & Director
Mr. Richard S. Nelson
Chief Medical Officer
Dr. Thomas Strack M.D., Ph.D.

See Also

Discover More
What is the Intrinsic Value of one VTVT stock?

The intrinsic value of one VTVT stock under the Base Case scenario is 8.19 USD.

Is VTVT stock undervalued or overvalued?

Compared to the current market price of 13.91 USD, vTv Therapeutics Inc is Overvalued by 41%.

Back to Top